[HTML][HTML] Laboratory findings and biomarkers in Long COVID: what do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and …
D Tsilingiris, NG Vallianou, I Karampela… - International Journal of …, 2023 - mdpi.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
D Tsilingiris, NG Vallianou, I Karampela… - International …, 2023 - search.proquest.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
D Tsilingiris, NG Vallianou, I Karampela… - 2023 - preprints.org
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far has affected about 65 …
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges …
D Tsilingiris, NG Vallianou, I Karampela… - … Journal of Molecular …, 2023 - europepmc.org
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
[引用][C] Laboratory findings and biomarkers in Long COVID: What do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and …
saxo.ku.dk
Tsilingiris, D, Vallianou, NG, Karampela, I, Christodoulatos, GS, Papavasileiou, G,
Petropoulou, D, Magkos, F & Dalamaga, M 2023,'Laboratory findings and biomarkers in …
Petropoulou, D, Magkos, F & Dalamaga, M 2023,'Laboratory findings and biomarkers in …
[引用][C] Laboratory findings and biomarkers in Long COVID: What do we know so far? Insights into epidemiology, pathogenesis, therapeutic perspectives and …
International Journal of Molecular Sciences, 2023 - nexs.ku.dk
Tsilingiris, D, Vallianou, NG, Karampela, I, Christodoulatos, GS, Papavasileiou, G,
Petropoulou, D, Magkos, F & Dalamaga, M 2023,'Laboratory findings and biomarkers in …
Petropoulou, D, Magkos, F & Dalamaga, M 2023,'Laboratory findings and biomarkers in …
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges …
D Tsilingiris, NG Vallianou… - International …, 2023 - search.ebscohost.com
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges
D Tsilingiris, NG Vallianou… - International …, 2023 - pubmed.ncbi.nlm.nih.gov
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
[PDF][PDF] Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and …
D Tsilingiris, NG Vallianou, I Karampela… - Int. J. Mol …, 2023 - researchgate.net
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
[HTML][HTML] Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and …
D Tsilingiris, NG Vallianou, I Karampela… - … Journal of Molecular …, 2023 - ncbi.nlm.nih.gov
Long COVID (LC) encompasses a constellation of long-term symptoms experienced by at
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …
least 10% of people after the initial SARS-CoV-2 infection, and so far it has affected about 65 …